how to choose among the phosphate binders for patients with chronic kidney disease

May 2011

There's confusion about how to choose among the phosphate binders for patients with chronic kidney disease.

These have similar efficacy for lowering phosphate levels...but they vary in adverse effects, cost, and number of pills needed.

Aluminum hydroxide isn't used chronically anymore. Aluminum accumulates and leads to bone disease, dementia, and death.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote